Sanofi position in QTTB
Q32 Bio Inc. · Health Care
Sanofi reported holding 244,083 shares of QTTB (Q32 Bio Inc.) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.32% of its reported portfolio and ranking #16 among its reported holdings. Sanofi has disclosed QTTB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR
How Sanofi's QTTB position evolved
Sanofi first disclosed a stake in QTTB in Q4 2024 at 244,083 shares (US$840K). The position peaked in Q2 2026 at 244,083 shares, worth US$3.1M. Across 8 filings, Sanofi held the position steady without any share-count change. The most recent filing (Q3 2026) shows 244,083 shares valued at US$2.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 244.08K | $839.65K | New |
| Q1 2025 | 244.08K | $402.74K | Hold |
| Q2 2025 | 244.08K | $363.68K | Hold |
| Q3 2025 | 244.08K | $483.28K | Hold |
| Q4 2025 | 244.08K | $810.36K | Hold |
| Q1 2026 | 244.08K | $1.57M | Hold |
| Q2 2026 | 244.08K | $3.11M | Hold |
| Q3 2026 | 244.08K | $2.02M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QTTB and 13F data
QTTB (Q32 Bio Inc.) is a Health Care company. 50 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- ORBIMED ADVISORS LLC 4.13M sh · $52.59M · Q2 2026
- Boxer Capital Management, LLC 3.15M sh · $40.12M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M sh · $34.62M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Opaleye Management Inc. 931.00K sh · $11.86M · Q2 2026
- Logos Global Management LP 800.00K sh · $10.19M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K sh · $2.75M · Q2 2026
- Carlyle Group Inc. 60.36K sh · $769.02K · Q2 2026
FAQ
How long has Sanofi held QTTB?
Sanofi has disclosed QTTB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Sanofi's current position in QTTB?
As of Q3 2026, Sanofi holds 244.08K shares of QTTB (Q32 Bio Inc.), valued at $2.02M, representing 0.32% of its reported portfolio and ranking #16.
Has Sanofi been buying or selling QTTB?
In the latest 13F filing (Q3 2026), Sanofi held unchanged its position in QTTB. The position peaked in Q2 2026 at 244.08K shares.
Which other funds hold QTTB?
Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.